Pharmalink AB has announced that it has gained an exclusive global license to Archimedes Pharma Ltd.’s TARGIT® drug delivery technology for use in its lead program, Nefecon® for the treatment of the ...
Pharmalink AB, today announces it has gained an exclusive global license to Archimedes Pharma Ltd.'s TARGIT® drug delivery technology for use in its lead program, Nefecon® for the treatment of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results